In October, Suki raised $90 million in Series E funding to expand beyond artificial intelligence (AI) scribing into clinical decision support, billing, and administrative work.[1]
Suki generates clinical notes from patient visits.[2] For practices choosing a documentation tool, its expansion raises a purchasing question: which additional tasks can the same assistant reliably handle within the practice's existing software?
Who Built Suki
Suki is based in Redwood City, California.[1] Founder and CEO Punit Soni started the company in 2017 to build a voice assistant for clinicians. He previously held product roles at Google and Motorola and served as chief product officer at Flipkart.[3]
Healthier Capital led the $90 million Series E, according to Axios.[4] The financing brings Suki's disclosed funding to approximately $258 million, adding to the $168 million it reported in January 2025.[1][5] Crosslink Capital, Hercules Capital, and existing investors also participated. Healthier Capital partner Aman Mahajan, MD, will join the board.[1]
What the Funding Will Support
Suki plans to invest in AI development, healthcare software integrations, its partner network, and sales operations. It sells its own clinician application and supplies technology that other software companies embed in their products.[1] For a practice, that makes the purchase route relevant: ask whether the capabilities demonstrated come through a direct Suki subscription or a partner's product, and who supports the integration.
What Changes With Ask
Suki already offered patient summaries, dictation, billing-code suggestions, and answers drawn from electronic health record (EHR) data before this round.[2]
Ask, launched in October across Epic, Oracle Health, athenahealth, and MEDITECH, adds access to UpToDate Expert AI within Suki's clinical workflow. Physicians can speak or type questions to retrieve chart details, including medications and laboratory results. Those with UpToDate access can also receive answers to medical questions with links to supporting clinical evidence.[6]
That gives practices a specific workflow to test: whether physicians can find and verify the information they need without repeating the search in another application. Suki describes Ask as an information retrieval and synthesis tool. Physicians review its answers and make care decisions; Ask does not diagnose patients or prescribe treatment plans.[7]
Where Suki Fits Among Competing Assistants
The matrix compares capabilities described in vendor documentation, checked in November 2026. Yes means the vendor documents the feature; Unconfirmed means the reviewed sources do not establish it. Availability can depend on the product package, specialty, and EHR integration.
Product | AI visit notes | Answers chart questions | Clinical-reference answers | Coding suggestions |
|---|---|---|---|---|
Suki [2][6][7] | Yes | Yes | Yes | Yes |
Abridge [8][9] | Yes | Yes | Yes | Yes |
Microsoft Dragon Copilot [10][11][12] | Yes | Yes* | Yes | Yes |
Ambience [13][14] | Yes | Yes | Yes† | Yes |
Nabla [15][16] | Yes | Unconfirmed | Unconfirmed | Yes‡ |
Chart questions concern the patient's existing record; clinical-reference answers draw on external medical knowledge.
* Dragon Copilot: Desktop focus mode answers questions using available chart content in the clinician's current workflow. This does not establish unrestricted search across the entire record.[12]
† Ambience: Chart Chat documents medical-literature access and a BMJ Best Practice integration described as beta at launch. Confirm current availability with the vendor.[14]
‡ Nabla: The cited app's billing-code workflow covers selected outpatient specialties and requires manual transfer into the EHR.[15] Its reviewed documentation does not establish chart-question answering. Its October OpenEvidence announcement was retracted, leaving clinical-reference answers unconfirmed as well.[16][17]
These offerings put Suki's expansion within a broader move toward clinical assistants. The $90 million round supports that direction, but does not establish a performance lead. For a practice comparing vendors, Ask's UpToDate integration is one concrete feature to weigh alongside the sources, integration, and review controls each alternative provides.
Four Questions to Bring to a Suki Demo
Use the practice's actual EHR configuration and representative test cases to get answers to these questions:
What is the full cost per clinician? Ask for a quote separating per-provider charges from organization-wide bundles. Identify whether Ask, coding assistance, EHR integration, implementation, and the required UpToDate access are included or priced separately.
How does Ask handle conflicting chart entries? Test a record where the medication list and a later visit note disagree. Does the answer flag the conflict, show both sources and their dates, or silently choose one? Have the physician open the original entries from the answer.
Can the billing team audit a code suggestion? Request the documentation and reasoning supporting it. Check whether reviewers can trace it to the encounter, correct it, and retain a record of the suggestion and their changes.
What can Suki write back into the EHR? Request a field-by-field demonstration covering notes, diagnoses, medication lists, and orders. Identify which actions the contracted version supports, which only create drafts, whose permissions apply, and where clinician approval is required.
Record the answers in the proposal and trial criteria so the practice can compare the demonstrated capabilities with what it will actually buy.
Sources
Suki. (2026, October 13). Suki Secures $90 Million to Build and Scale AI Agents for Health Systems and Health Tech Companies. Read the Series E financing announcement.
Wolters Kluwer Health. (2025, March 3). Wolters Kluwer and Suki to integrate UpToDate's trusted physician-authored content into Suki Assistant. Read the partnership and product description.
Kinsella, Bret. (2020, June 28). Punit Soni Founder and CEO of Suki the Voice Assistant for Healthcare: Voicebot Podcast Ep 156. Voicebot.ai. Read the founder interview introduction and show notes.
Maddox, Will, and Brock E.W. Turner. (2026, October 17). Health tech deals of the week. Axios. Read the funding-round report.
Suki. (2025, January 30). Suki Announces Investment from Zoom Ventures Following Platform Partnership for Healthcare Business. Read the investment and partnership announcement.
Suki and Wolters Kluwer Health. (2026, October 8). Suki Launches “Ask,” Accelerating Complex Clinical Decision Support Powered by Wolters Kluwer UpToDate Expert AI. Read the Ask launch announcement.
Bafna, Himanshu. (2026, October 8). Ask: seamless information retrieval and synthesis at the point of care. Suki. Read the product explanation and clinical-use boundaries.
Abridge. (Accessed 2026, November 8). Abridge Assistant. Read the clinical assistant product description.
Abridge. (Accessed 2026, November 8). Ambient AI for Revenue Cycle. Read the documentation and coding capabilities.
Microsoft. (2025, March 3). Microsoft Dragon Copilot provides the healthcare industry’s first unified voice AI assistant that enables clinicians to streamline clinical documentation, surface information and automate tasks. Read the Dragon Copilot announcement.
Microsoft. (Accessed 2026, November 8). Use AI prompts for coding. Read the Dragon Copilot coding guidance.
Microsoft. (Accessed 2026, November 8). Use AI where you work. Read the desktop focus-mode chart-query workflow.
Ambience Healthcare. (Accessed 2026, November 8). Business solutions: coding, compliance, and clinical workflows. Read the product capabilities.
Ambience Healthcare. (2025, August 18). Ambience Healthcare Unveils Chart Chat: The First AI Copilot Built Into the EHR. Read the Chart Chat launch and medical-reference capabilities.
Nabla. (2026, May 28). E/M Coding: How It Works. Read the coding workflow and availability limits.
Nabla. (Accessed 2026, November 8). Features. Review the documented application features.
Nabla. (2026, October 15). DISREGARD RELEASE: Nabla. PR Newswire, syndicated by NEWSnet. Read the OpenEvidence announcement retraction.